mmm. A 13% growth in procedures from the 3rd qtr to the 4th qtr is not that impressive when the 3rd qtr covered the northern summer. They need growth rates well north of 50% qtr on qtr.
Did anyone ask why the surgeons are so reluctant to use the product? What is the growth rate in usage with surgeons who first used it 12 months ago? Are they seeing any pick up in usage with familiarity or has the product fallen into a small niche - the sort of thing that is only used by surgeons every few months?
Ann: Appendix 4C, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.1¢ | $3.052K | 1.651M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 43009120 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 90779583 | 59 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
